On: Skin cancer: Half of people surviving advanced mel...

[pflats]

> That sounds like checkpoint inhibitor immunotherapy.

You are correct. That is because the article is about checkpoint inhibitor immunotherapy (specifically yervoy/ipilimumab and opdivo/nivolumab).